Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100

Cencora, Inc. (COR) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Cencora, Inc. (COR) trades at a EV/FCF of 18.2×. Over the past ten years it has ranged from −91.3× (March 2025) to 57.6× (September 2025); the current reading is higher than 81% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 19.9× 29.98%
FY2024 15.3× 37.58%
FY2023 11.1× (19.48%)
FY2022 13.8× 7.28%
FY2021 12.9× 24.74%
FY2020 10.3× 14.20%
FY2019 9.1× (56.20%)
FY2018 20.7× 9.72%
FY2017 18.8× 171.03%
FY2016 7.0× 41.56%

Quarterly newest first

Period EV/FCF Change
Jun 2026 15.5× (65.23%)
Mar 2026 44.5× 126.47%
Dec 2025 19.7× (1.29%)
Sep 2025 19.9× (64.54%)
42 more quarters

Against its own ten years

Low −91.3× High 57.6×
Ten-year median 13.6×
Current reading's percentile 79

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on COR